results found
The cost of prescription drugs has become a hot-button issue with consumers and policymakers. One in four people taking prescription drugs report difficulty affording their medication and recent Kaiser Family Foundation opinion polling has found bipartisan support for government action …
The U.S. has lower than average mortality rates for cancers but higher than average rates in the other causes of mortality. This collection of charts explores how mortality rates in the U.S. compare to similar OECD countries (those that are …
In a given year, a small portion of the population is responsible for a very large percentage of total health spending. We tend to focus on averages when discussing health spending, but individuals’ health status – and thus their need …
An updated version of this analysis is available here.
Prescription drug spending grew rapidly between 2014 and 2015, but increases have been more modest recently. Several studies by the federal government, pharmacy benefit managers, and insurers point to high prices …
Total health spending is a function of both price paid to providers or for drugs and the volume of services used. These charts explore prices and use of health services in the U.S. relative to comparable countries (those with both …
In this analysis, we explore trends in prices for health services over time in the U.S. (A related chart collection shows trends in prices and utilization in the U.S. and comparable countries). We find that prices have increased for a …
This collection of charts complements our brief, “A look at how the opioid crisis has affected people with employer coverage,” which uses claims data from large employers to examine how the opioid crisis has affected people with large employer coverage, …
This collection of charts explores international comparisons of social, environmental, and economic factors that influence health but are in some respects outside the control of the health system. Relative to similarly wealthy countries, the U.S. has worse life expectancy, mortality, …
This collection of charts (updated July 31, 2017) explores trends in the prevalence, outcomes, costs, and access to care associated with mental health and substance use disorders in the United States and comparably wealthy countries. A related brief offers discussion …
This collection of charts and a related brief explore trends in the costs of treating diseases. The Bureau of Economic Analysis (BEA) disease-based health spending estimates allows users to examine national health spending trends by disease category from 2000 – …